Skip to main content

ICE Make Q2 top-line grows 20% to 30.06 - Crore

 

Company fully geared to serve cold chain requirements of Covid19 Vaccination drive



Ice Make Refrigeration Limited (Ice Make), leading supplier of innovative cooling solutions and manufacturer of 50 plus refrigeration equipments, has posted total revenue of Rs 30.06 Cr. for Q2FY21.

Despite ongoing global pandemic challenges, the company’s top line stood marginally up by 20% as compared to Rs. 25.25 Cr. recorded in the corresponding period of Q2FY20.

The standalone and consolidated net profit for this period stood at Rs 1.91 Cr. and Rs 1.84 Cr. respectively compared to -0.28 Cr. and Rs 0.18 Cr. reported in Q2FY20.


Company’s Chairman and Managing Director Mr Chandrakant Patel, said, Ice Make has performed much better despite huge challenges posed by ongoing Covid-19 global pandemic. We have developed & set up a proactive “End-To-End Cold Chain Systems” for pharma industries, hospitals, procurement agencies and government health care system.

The Company is fully geared to tap opportunities and provide the cold chain solutions to health care stakeholders for the much awaited Covid19 Vaccination Drive, across the country.

 

Other Key Updates

Ø The standalone and consolidated top line for H1FY21 stood at Rs 47.16 Cr. and Rs 47.74 Cr. respectively in H1FY21.

Ø  The standalone and consolidated net profit for H1FY21 stood at Rs 0.96 Cr. and Rs0.48 Cr. respectively in H1FY21.

Ø During the period company’s EBIDTA margin stood at 8.17 % as compared to 6.74 % for corresponding period of H1FY20.

Ø Two years ago in December 2017 Ice Make began its capital market journey with a record subscription and stellar response to its maiden SME IPO. This year from 12 Oct 2020, the Company has migrated to the main board of NSE -The National Stock Exchange.

Ø Ice Make has a basket of 50 plus innovative products and services that are placed in such a manner and helping the company overcome the prevailing weakness in the overall market.

 

Ø For more updates, the Company will hold Earnings Conference Call to discuss the H1FY21results on Friday 18 December 2020 at 4.00 PM onwards

About Ice Make Refrigeration Ltd

Ice Make has been successfully satisfying the needs of its customers, from production to after-sales service, since 1993. The Company is engaged in the business of providing customized cooling solutions to diverse set of clients across wide range of industries by manufacturing and supply of high quality refrigeration products & equipment’s.

The Company operates under five key business verticals including Cold Room, Commercial Refrigeration, Industrial Refrigeration, Transport Refrigeration& Ammonia Refrigeration and caters to wide range of Industries including Dairy, Ice-cream, food processing, agriculture, pharmaceuticals, Cold Chain, Logistics, hospitals, Hospitality and retail among others. The Company also exports it’s products to overseas clients in number of countries. Ice Make has its manufacturing plants located at Dantali, near Ahmedabad, Gujarat and Chennai.

The Company over the years have received several awards and accolades including Indian Leadership Award for Industrial Development in 2011, Best Medium Enterprise (Manufacturing) by Canara Bank &Skoch Award in 2014, India SME 100Award in 2017 and Gold Award for excellence within its core industry category &2017-18 Vision Award for Annual Report Competition” hosted by the League of American Communications Professionals LLC (LACP) where ICE Make was ranked 27th among the top 100 annual reports globally.

Comments

Post a Comment

Popular posts from this blog

Country Delight Launches NMR-Tested Honey: The Gold Standard of Purity

  Country Delight continues strengthening its promise of delivering the best purity and quality by launching 100% Pure Farm Honey (NMR Tested) Country Delight, a trusted name in premium and natural essentials, has announced the launch of 100% Pure Farm Honey (NMR Tested). Country Delight’s Farm Honey is Nuclear Magnetic Resonance (NMR) tested by a certified lab in Germany, making it one of the most authentic and reliable kitchen ingredients available to Indian homes. It also undergoes rigorous testing on 36 quality parameters as per FSSAI standards, including physicochemical, antibiotic and microbial, to rule out the presence of added sugars. Honey is not just a natural sweetener; it is increasingly valued for its functional benefits. With Country Delight's NMR-tested honey, consumers can enjoy a product that supports wellness through its natural composition, which is rich in antioxidants and phytonutrients and offers advantages over refined sugars.  Adulteration with cheaper ...
Post a Comment
Read more

Prachay Capital’s Public Issue of Secured NCDs Lists on BSE Platform

Prachay Capital Limited, an RBI-registered Non-Banking Financial Company – Investment and Credit Company (NBFC-ICC), has officially listed its Secured, Rated, Redeemable Non-Convertible Debentures (NCDs) on the BSE Limited, unlocking new investment opportunities. The company successfully closed its public issue with an impressive 106% subscription, highlighting strong investor confidence. The issue, which opened on February 28, 2025, aimed to raise Rs 50 crore (excluding the greenshoe option) and closed on March 13, 2025. This landmark listing reinforces Prachay Capital’s commitment to providing stable, high-yield investment opportunities in the fixed-income sector, even amid volatile equity market conditions. The BBB-/Stable-rated NCDs by CRISIL, offering an attractive 13% per annum return with monthly interest payouts, present a compelling option for investors seeking secure fixed-income avenues. The listing event was graced by Ketan Jantre, Head of Trading Operations, BSE; Giri...
Post a Comment
Read more

Prachay Capital’s Public Issue of Secured NCDs Fully Subscribed at 113.36%

Prachay Capital Limited, an RBI-registered Non-Banking Financial Company – Investment and Credit Company (NBFC-ICC), has successfully closed its public issue of Secured, Rated, Redeemable Non-Convertible Debentures (NCDs) at 113.36% subscription, according to exchange data. The issue, which opened on February 28, 2025, on the Bombay Stock Exchange (BSE), aimed to raise Rs 50 crore (excluding the greenshoe option) and closed on March 13, 2025. With a BSE listing, this issue was open for subscription to retail investors, high-net-worth individuals (HNIs), institutional investors, and corporates. The maiden NCDs issue is scheduled to list on 24 March 2025.  Rated BBB-/Stable by CRISIL, these NCDs offer investors a 13% per annum return with monthly interest payouts, making them an attractive fixed-income opportunity. The proceeds will be deployed as per the company’s stated fund allocation plan. Fund Utilization: Minimum 75% for the purpose of onward lending, investments in current and...
Post a Comment
Read more